liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
University of South Denmark.
University of South Denmark.
Linköpings universitet, Institutionen för medicin och hälsa, Klinisk farmakologi. Linköpings universitet, Hälsouniversitetet.
Odense University Hospital.
Vise andre og tillknytning
2011 (engelsk)Inngår i: PHARMACOGENOMICS JOURNAL, ISSN 1470-269X, Vol. 11, nr 2, s. 113-120Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

The primary purpose of this study was to evaluate the effect of CYP2C8*3 and three genetic ABCB1 variants on the elimination of paclitaxel. We studied 93 Caucasian women with ovarian cancer treated with paclitaxel and carboplatin. Using sparse sampling and nonlinear mixed effects modeling, the individual clearance of unbound paclitaxel was estimated from total plasma paclitaxel and Cremophor EL. The geometric mean of clearance was 385 l h(-1) (range 176-726 l h(-1)). Carriers of CYP2C8*3 had 11% lower clearance than non-carriers, P = 0.03. This has not been shown before in similar studies; the explanation is probably the advantage of using both unbound paclitaxel clearance and a population of patients of same gender. No significant association was found for the ABCB1 variants C1236T, G2677T/A and C3435T. Secondarily, other candidate single-nucleotide polymorphisms were explored with possible associations found for CYP2C8*4 (P = 0.04) and ABCC1 g.7356253C andgt; G (P = 0.04).

sted, utgiver, år, opplag, sider
Nature Publishing Group , 2011. Vol. 11, nr 2, s. 113-120
Emneord [en]
CYP2C8, ABCB1, P-glycoprotein, paclitaxel, cremophor, ovarian cancer
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-67364DOI: 10.1038/tpj.2010.19ISI: 000288849900005OAI: oai:DiVA.org:liu-67364DiVA, id: diva2:409710
Merknad
Original Publication: T K Bergmann, C Brasch-Andersen, Henrik Green, M Mirza, R S Pedersen, F Nielsen, K Skougaard, J Wihl, N Keldsen, P Damkier, L E Friberg, Curt Peterson, W Vach, M O Karlsson and K Brosen, Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer, 2011, PHARMACOGENOMICS JOURNAL, (11), 2, 113-120. http://dx.doi.org/10.1038/tpj.2010.19 Copyright: Nature Publishing Group http://npg.nature.com/ Tilgjengelig fra: 2011-04-11 Laget: 2011-04-11 Sist oppdatert: 2011-09-06

Open Access i DiVA

fulltext(821 kB)1425 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 821 kBChecksum SHA-512
889fa7791cc1630f4577f2461903a1966320b950e54b55a50a7db1eebebb0285e4f086eca171bc6076a563c48011b272c35d416db56a99b6f480ec3b04a39a7e
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekst

Personposter BETA

Green, HenrikPeterson, Curt

Søk i DiVA

Av forfatter/redaktør
Green, HenrikPeterson, Curt
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 1425 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 292 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf